Anticipated as well as recently launched global bioresorbable coronary stents market will trigger a revenue increase to USD 247 million by 2025. According to a new report by Grand View Research, Inc., better device attributes of second-generation coronary stents will provide the ascending push to this market.
Bioresorbable stents are
intended majorly for the young adult population, whereby these individuals are
enabled with a normal functioning artery following complete resorption of the
dissolvable devices.Lifestyle diseases and prevalence of associated risk
factors underpin the growth in atherosclerosis-related cardiac events. This
drives the global disease prevalence in young adults as well as the high volume
of elective Percutaneous Coronary Interventions (PCI).
What sets the
second-generation bioresorbable coronary stents apart? – Learning from past
mistakes, manufacturers have developed new generation bioresorbable with
thinner strut thicknesses, faster resorption times, and better radial force.
Amaranth, with a single-minded focus on strut thickness, has developed three
such devices. Each with a thinner strut. The latest, Magnitude boasts of 100
microns.
Another factor providing
a fillip to this market is the less-invasive nature of PCIs as compared to
coronary artery bypass grafting, resulting in their high elective procedure volume.
In most parts of the world, lack of auditing to check inappropriate surgeries
drives the number of coronary stenting procedures. Hence, this market is
expected to witness growth due to the high volume of elective PCI, particularly
in APAC and Europe.
Browse full report by Grand View
Research : http://www.grandviewresearch.com/industry-analysis/bioresorbable-coronary-stents-market
Further Key Findings From the Study Suggest:
·
Europe region is the major contributor for
the bioresorbable stents market in 2016. Subsequent to withdrawal of the
bioresorbable Absorb BVS, emergence of CE-approved bioresorbable stents hold
strong growth prospects for greater sales in the member countries.
·
APAC follows Europe with almost 30% segment
share and is expected to record the fastest growth in the future
·
Absorb BVS, among the key brands,
engendered the highest sales revenue in 2016, while Absorb 2nd generation device will supersede the
sales of its rival devices toward the end of the forecast period
·
North America trails behind as the smallest
revenue generator against leading counterparts, Europe and APAC, in this
market. Downfall of Abbott’s Absorb BVS, the only approved FDA device, is the
underlying reason for the small segment share in the U.S. region.
·
Key players in this space include
BIOTRONIK, Meril Lifesciences Pvt. Ltd., Abbott, Elixir Medical Corporation,
REVA Medical, Arterial Remodeling Technologies, and Amaranth Medical
·
Strategic efforts undertaken by the
companies to gain a higher market share center on bioresorbable coronary stents
development. Companies targeting the clinical pipeline have developed
second-generation bioresorbable products with better design specifications,
such as devices with thinner strut thicknesses and faster absorption rates that
gain comparability with the gold standard, drug-eluting metallic stents.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has
segmented the bioresorbable coronary stents market by brands and region:
Bioresorbable Coronary Stents Brand Outlook (Revenue, USD
Million;2016-2025)
·
Absorb BVS
·
Absorb 2nd Generation
·
Magmaris
·
Magnitude
·
MeRes-100
·
DESolve
Bioresorbable Coronary Stents Regional Outlook
(Revenue, USD Million; 2016-2025)
·
North America
o U.S.
o Canada
·
Europe
o UK
o Germany
o France
o Italy
o Spain
·
Asia Pacific
o Japan
o India
View Press Release of this research
report by Grand View Research: http://www.grandviewresearch.com/press-release/global-bioresorbable-coronary-stents-market
About Grand View Research
Grand View
Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment